Abstract
Despite intensive multimodal treatment, outcome of patients with malignant glioma remains poor, and a standard dose of radiotherapy for anaplastic astrocytoma has not been defined. In the past RTOG study (83-02), the arm of 72 Gy hyperfractionated radiotherapy (HFRT) for malignant gliomas showed better outcome than the arms of higher doses (76.8 - 81.6 Gy) and the arms of lower doses (48 - 54.4 Gy). The purpose of this study is to verify the efficacy of this protocol. From July 1995, 44 consecutive eligible patients with histologically proven anaplastic astrocytoma were enrolled in this study (HFRT group). The standard regimen in this protocol was post-operative radiotherapy of 72 Gy in 60 fractions (1.2 Gy/fraction, 2 fractions/day) with concurrent chemotherapy (weekly ACNU). The primary endpoint was local control rate (LCR), and the secondary endpoints were overall survival (OS), progression-free survival (PFS) and late toxicity. Three-year OS of the HFRT group was 64.8% (95% confidence interval; 48.4-81.3%). Three-year PFS rate and LCR were 64.4% (95%CI: 48.4-80.3%) and 81.6% (95%CI: 69.2-94.8%), respectively. The number of failures at 5 years in the HFRT group were 14 (32%). The number of failures inside the irradiation fie...Continue Reading
References
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·M StuschkeH Sack
Aug 1, 1990·International Journal of Radiation Oncology, Biology, Physics·P J MillerR G Evans
Mar 1, 1990·International Journal of Radiation Oncology, Biology, Physics·A L ZietmanR S Sedlacek
Feb 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R WoodW R Shapiro
Jul 1, 1994·International Journal of Radiation Oncology, Biology, Physics·P K SneedW M Wara
Oct 20, 1993·International Journal of Radiation Oncology, Biology, Physics·M StuschkeH Sack
Jan 15, 1993·International Journal of Radiation Oncology, Biology, Physics·D F NelsonM Mohiuddin
May 20, 1993·International Journal of Radiation Oncology, Biology, Physics·J R SimpsonJ S Nelson
May 5, 1993·Journal of the National Cancer Institute·W J CurranR E Krisch
Apr 15, 1996·Cancer·M Werner-WasikW J Curran
Jan 15, 1996·Cancer·S P LeonP M Black
Dec 1, 1996·International Journal of Radiation Oncology, Biology, Physics·R C UrtasunD S Fulton
Jan 9, 1998·International Journal of Radiation Oncology, Biology, Physics·M D PradosC B Wilson
Feb 16, 1999·International Journal of Radiation Oncology, Biology, Physics·S W LeeH M Sandler
Feb 25, 1999·International Journal of Radiation Oncology, Biology, Physics·M BradaS Ashley
Jul 1, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·B JeremicJ Aleksandrovic
Sep 8, 2001·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·H AydinH von Lieven
May 15, 2002·International Journal of Radiation Oncology, Biology, Physics·V A LevinM H Maor
Feb 6, 2003·Cancer·Avelina TortosaFrancesc Graus